Condensed Consolidated Statements of Stockholders' Deficit - 9 months ended Sep. 30, 2015 - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balances at Dec. 31, 2014	$ 27,113	$ 10,778,807	$ (11,231,967)	$ (426,047)
Balances (in shares) at Dec. 31, 2014	27,112,263
Common stock and options issued for services	$ 880	315,310		316,190
Common stock and options issued for services (in shares)	880,625
Common stock and RSUs issued for board compensation		140,996		140,996
Common stock and RSUs issued for board compensation (in shares)
Common stock and options issued for product acquisition	$ 12,948	2,058,678		2,071,626
Common stock and options issued for product acquisition (in shares)	12,947,657
Stock based compensation expense		831,807		831,807
Common stock issued upon conversion of debt, of which 1,579,297 shares were issued to related parties	$ 699	166,301		$ 167,000
Common stock issued upon conversion of debt (in shares)	699,260
Common stock issued for RSU conversion	$ 500	(500)
Common stock issued for RSU conversion (in shares)	500,000
CRI Share reduction	$ (200)	(37,800)		$ (3,800)
CRI Share reduction (in shares)	(200,000)
Semprae merger transaction share return	$ (386)	(115,437)		(115,823)
Semprae merger transaction share return (in shares)	(386,075)
Fair Value of Beneficial conversion on line of credit		6,275		6,275
Shares issued for extension of February 2014 convertible debentures	$ 250	32,250		32,500
Shares issued for extension of February 2014 convertible debentures (in shares)	250,000
Shares issued for extension of January 2015 convertible debentures	$ 100	15,400		15,500
Shares issued for extension of January 2015 convertible debentures (in shares)	100,000
Shares issued in connection with 3rd quarter financing	$ 4,337	320,913		325,250
Shares issued in connection with 3rd quarter financing (in shares)	4,337,500
Warrants issued in connection with 3rd quarter financing		138,775		138,775
Warrants issued in connection with 3rd quarter financing (in shares)
Deferred financing costs in connection 3rd quarter financing		$ 68,419		68,419
Deferred financing costs in connection 3rd quarter financing (in shares)
Net loss			$ (3,224,778)	(3,224,778)
Balances at Sep. 30, 2015	$ 46,241	$ 14,720,194	$ (14,456,745)	$ 309,690
Balances (in shares) at Sep. 30, 2015	46,241,230